(3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid

C19H17BrClF3N4O4 — CID 141361351

IUPAC(3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid
SMILESC[C@@H]1CN(C(=O)O)CCN1c1ccc(NC(=O)c2cc(OC(F)(F)F)c(Br)cc2Cl)cn1
InChIInChI=1S/C19H17BrClF3N4O4/c1-10-9-27(18(30)31)4-5-28(10)16-3-2-11(8-25-16)26-17(29)12-6-15(32-19(22,23)24)13(20)7-14(12)21/h2-3,6-8,10H,4-5,9H2,1H3,(H,26,29)(H,30,31)/t10-/m1/s1
InChIKeyGAOHCAHGFRDTHG-SNVBAGLBSA-N
MW537.72 g/mol
LogP4.84
Rot. Bonds4

About (3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid

(3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid (PubChem CID 141361351) has the molecular formula C19H17BrClF3N4O4 and a molecular weight of 537.72 g/mol. Its IUPAC name is (3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid.

Molecular Properties

Compound Name(3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid
PubChem CID141361351
Molecular FormulaC19H17BrClF3N4O4
Molecular Weight537.72 g/mol
Exact Mass536.01
IUPAC Name(3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid
SMILESC[C@@H]1CN(C(=O)O)CCN1c1ccc(NC(=O)c2cc(OC(F)(F)F)c(Br)cc2Cl)cn1
InChIInChI=1S/C19H17BrClF3N4O4/c1-10-9-27(18(30)31)4-5-28(10)16-3-2-11(8-25-16)26-17(29)12-6-15(32-19(22,23)24)13(20)7-14(12)21/h2-3,6-8,10H,4-5,9H2,1H3,(H,26,29)(H,30,31)/t10-/m1/s1
InChIKeyGAOHCAHGFRDTHG-SNVBAGLBSA-N
XLogP4.84
TPSA95.00 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms32
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500537.72
LogP ≤ 54.84
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze (3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid?
The IUPAC name of (3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid (CID 141361351) is (3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid.
What is the SMILES notation for (3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid?
The canonical SMILES for (3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid is C[C@@H]1CN(C(=O)O)CCN1c1ccc(NC(=O)c2cc(OC(F)(F)F)c(Br)cc2Cl)cn1.
What is the InChIKey of (3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid?
The InChIKey is GAOHCAHGFRDTHG-SNVBAGLBSA-N. The full InChI is InChI=1S/C19H17BrClF3N4O4/c1-10-9-27(18(30)31)4-5-28(10)16-3-2-11(8-25-16)26-17(29)12-6-15(32-19(22,23)24)13(20)7-14(12)21/h2-3,6-8,10H,4-5,9H2,1H3,(H,26,29)(H,30,31)/t10-/m1/s1.
What are the key properties of (3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid?
(3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid has a molecular weight of 537.72 g/mol, XLogP of 4.84, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-4-[5-[[4-bromo-2-chloro-5-(trifluoromethoxy)benzoyl]amino]-2-pyridinyl]-3-methylpiperazine-1-carboxylic acid is sourced from PubChem (CID 141361351), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).